healio.com

8 articles in the TruthFoundry index. Each links out to the original.

• Study: Hemodiafiltration Linked to Lower Mortality Than High-Flux Dialysis · A multinational study finds hemodiafiltration reduces all-cause mortality compared to high-flux hemodialysis.
• Mayo Clinic Nephrologist Praises GlomCon Hawaii's Rare Disease Focus · Paul E. Hanna, MD, calls GlomCon Hawaii a favorite meeting dedicated to rare glomerular diseases.
• Expert Discusses IgA Nephropathy Trials and Future Research · Paul E. Hanna, MD, discusses phase 3 IgA nephropathy trials and future study designs at GlomCon Hawaii.
• Dialysis Patients Face Risks as Vascular Access Centers Close · Low Medicare reimbursement threatens community vascular access centers, increasing reliance on dangerous catheters for dialysis patients.
• GlomCon Hawaii fosters open debate in positive medical environment · Dana Rizk describes GlomCon Hawaii as a collegial forum encouraging open questioning and debate.
• Dana Rizk Discusses Designing Phase 4 Trials for IgA Nephropathy · Dana Rizk explains the transition from clinical trial efficacy to real-world effectiveness in IgA nephropathy.
• Sibeprenlimab Shows Remarkable Results in IgA Nephropathy Trial · Dana Rizk reports remarkable efficacy and solid safety for sibeprenlimab in treating IgA nephropathy.
• Medicare Secondary Payer Act May Cost Federal Government Billions in Lost Tax Revenue · Study finds Medicare Secondary Payer Act causes federal government to lose billions annually in forgone tax revenue on dialysis.